Total Equity - Hofseth Biocare ASA (OSE:HBC) - Alpha Spread

Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.705 NOK -4.21% Market Closed
Market Cap: 610.1m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Hofseth Biocare ASA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hofseth Biocare ASA
Total Equity Peer Comparison

Comparables:
B
BGBIO
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Hofseth Biocare ASA
OSE:HBC
Total Equity
kr156.4m
CAGR 3-Years
-13%
CAGR 5-Years
18%
CAGR 10-Years
12%
B
Bergenbio ASA
OSE:BGBIO
Total Equity
kr93.3m
CAGR 3-Years
-46%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Total Equity
kr51.3m
CAGR 3-Years
37%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Total Equity
kr313.6m
CAGR 3-Years
14%
CAGR 5-Years
46%
CAGR 10-Years
25%
N
Nykode Therapeutics ASA
OSE:NYKD
Total Equity
$158.7m
CAGR 3-Years
-3%
CAGR 5-Years
32%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Total Equity
kr271.9m
CAGR 3-Years
15%
CAGR 5-Years
-6%
CAGR 10-Years
N/A

See Also

What is Hofseth Biocare ASA's Total Equity?
Total Equity
156.4m NOK

Based on the financial report for Mar 31, 2024, Hofseth Biocare ASA's Total Equity amounts to 156.4m NOK.

What is Hofseth Biocare ASA's Total Equity growth rate?
Total Equity CAGR 10Y
12%

Over the last year, the Total Equity growth was 38%. The average annual Total Equity growth rates for Hofseth Biocare ASA have been -13% over the past three years , 18% over the past five years , and 12% over the past ten years .

Back to Top